Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial. - Houot R; Bachy E; Cartron G; Gros FX; Morschhauser F; Oberic L; Gastinne T; Feugier P; Duléry R; Thieblemont C; Joris M; Jardin F; et al. (Nature medicine, 2024)